Región HLA y patología osteoarticular: aspectos fundamentales y aplicaciones clínicas

Dausset, 1958, Iso-leuco-anticorps, Acta Haematol., 20, 156, 10.1159/000205478 McCluskey, 1999, The human leucocyte antigens and clinical medicine: an overview, Rev. Immunogenet., 1, 3 Terasaki, 1964, Microdroplet assay of human serum cytotoxins, Nature, 204, 998, 10.1038/204998b0 Rhodes, 1999, Genetics and molecular genetics of the MHC, Rev. Immunogenet., 1, 21 Forbes, 1999, The MHC quartely report, Immunogenetics, 50, 152, 10.1007/s002510050591 McDonald, 1978, Soluble HLA: a review of the literature, Hum. Immunol., 59, 387, 10.1016/S0198-8859(98)00033-0 Bjorkman, 1987, Structure of the human class I histocompatibility antigen HLA-A2, Nature, 329, 506, 10.1038/329506a0 Brown, 1993, Three dimensional structure of the human class II histocompatibility antigen HLA-DR1, Nature, 364, 33, 10.1038/364033a0 Hammerling, 1999, Antigen processing and presentation-towards the Millenium, Immunol. Rev., 172, 5, 10.1111/j.1600-065X.1999.tb01351.x Parham, 1999 Marsh, 2010, Nomenclature Committee for Factor of the HLA System, Hum. Immunol., 71, 1033 Gould, 1999, Direct and indirect recognition: the role of MHC antigens in graft rejection, Immunol. Today, 20, 77, 10.1016/S0167-5699(98)01394-2 Flavel, 1999, Autoimmunity. Curr. Opin. Immunol., 11, 635, 10.1016/S0952-7915(99)00029-1 Thorsby, 1997, Invited anniversary review: HLA associated diseases, Hum. Immunol., 53, 1, 10.1016/S0198-8859(97)00024-4 Tiwari, 1985 Hors, 1997, HLA et maladies, un anniversaire, Presse Med., 26, 1300 Benjamin, 1990, Guilt by association: HLA-B27 and ankylosing spondylitis, Immunol. Today, 11, 137, 10.1016/0167-5699(90)90051-A Khalil, 1990, A combinaison of HLA-DQßAsp57-negative and HLA-DQα a Arg 52 confer susceptibility to insulin-dependant diabetes mellitus, J. Clin. Invest., 58, 1315, 10.1172/JCI114569 Todd, 1987, HLA-DQ βgene contributes to susceptibility and resistance to insulin-dependant diabetes mellitus, Nature, 329, 599, 10.1038/329599a0 Perdriger, 1996, Role of HLA DR. DR and DR/DP interaction in the genetic susceptibility to rheumatoid arthritis, Hum. Immunol., 46, 114, 10.1016/0198-8859(95)00217-0 Yaouanq, 1997, Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS, Science, 276, 664, 10.1126/science.276.5313.661g Semana, 1997, Graves’ disease study Sebzda, 1999, Selection of the T cell repertoire, Annu. Rev. Immunol., 17, 829, 10.1146/annurev.immunol.17.1.829 Hill, 1992, Molecular analysis of the association of HLA-B53 and resistance to severe malaria, Nature, 360, 434, 10.1038/360434a0 Hill, 1998, The immunogenetics of human infectious diseases, Annu. Rev. Immunol., 16, 593, 10.1146/annurev.immunol.16.1.593 Andrews N.C. Disorders of iron metabolism. N. Engl. J. Med. 1999;341:1986–5. (erratum, N Engl J Med 2000;342:342–64). Lebron, 1998, Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor, Cell, 93, 111, 10.1016/S0092-8674(00)81151-4 Chemelli, 1999, Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation, Cell, 98, 437, 10.1016/S0092-8674(00)81973-X Wordsworth, 1998, HLA-B27, ankylosing spondylitis and the spondylarthropathies Reveille, 2005, Spondylarthritis: update on pathogenesis and management, Am. J. Med., 118, 592, 10.1016/j.amjmed.2005.01.001 Saraux, 2005, Prevalence of spondylarthropathies in France: 2001, Ann. Rheum. Dis., 64, 1431, 10.1136/ard.2004.029207 Brewerton, 1973, Ankylosing spondylitis and HL-A27, Lancet, 1, 904, 10.1016/S0140-6736(73)91360-3 Brown, 2009, Genetics and pathogenesis of ankylosing spondylitis, Curr. Opin. Rheumatol., 21, 318, 10.1097/BOR.0b013e32832b3795 Breban, 2003, Familial and genetic aspects of spondylarthropathy, Rheum. Dis. Clin. North Am., 29, 575, 10.1016/S0889-857X(03)00029-2 Said-Nahal, 2000, The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe français d’étude génétique des spondylarthropathies, Arthritis Rheum., 43, 1356, 10.1002/1529-0131(200006)43:6<1356::AID-ANR20>3.0.CO;2-Y Said-Nahal, 2001, Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy, Arthritis Rheum., 45, 478, 10.1002/1529-0131(200112)45:6<478::AID-ART372>3.0.CO;2-I Said-Nahal, 2002, The role of HLA genes in familial spondylarthropathy: a comprehensive study of 70 multiplex families, Ann. Rheum. Dis., 61, 201, 10.1136/ard.61.3.201 Porcher, 2005, Two major spondylarthropathy phenotypes are distinguished by pattern analysis in multiplex families, Arthritis Rheum., 53, 263, 10.1002/art.21070 Brown, 1997, Susceptibility to ankylosing spondylitis in twins. The role of genes, HLA and the environment, Arthritis Rheum., 40, 1823, 10.1002/art.1780401015 Mathieu, 2009, The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: an unifying hypothesis, Autoimmunn. Rev., 8, 420, 10.1016/j.autrev.2009.01.003 Khan, 1998, Spondylarthropathies, Curr. Opin. Rheumatol., 10, 279, 10.1097/00002281-199807000-00001 Ball, 2001, HLA-B27 polymorphism, Joint Bone Spine, 68, 378, 10.1016/S1297-319X(01)00294-9 Khan, 2010, Remarkable polymorphism of HLA-B27: an ongoing saga, Curr. Rheumatol. Rep., 12, 337, 10.1007/s11926-010-0126-x Toussirot, 2006, Immunogénétique de la spondylarthrite ankylosante, Rev. Med. Interne, 27, 762, 10.1016/j.revmed.2006.05.005 Bownes, 2002, HLA B27 in health and disease: a double-edged sword, Rheumatol., 41, 857, 10.1093/rheumatology/41.8.857 Lopez de Castro, 1998, The pathogenic role of HLA-B27 in chronic arthritis, Curr. Opin. Immunol., 10, 59, 10.1016/S0952-7915(98)80033-2 Allen, 1999, The role of HLA-B27 in spondylarthritis, Immunogenetics, 50, 220, 10.1007/s002510050596 McMichael J., Bownes P. HLA-B27: natural function and pathogenic role in spondylarthritis. Arthritis Res. 2002;4:S153–S158. Allen, 1999, Cutting edge: HLA-B27 can form a novel beta 2-microglobulin free heavy chain homodimer structure, J. Immunol., 162, 5045, 10.4049/jimmunol.162.9.5045 Taurog, 1998, Animal models of the spondylarthropathies Hammer, 1990, Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27 associated disorder, Cell, 63, 1099, 10.1016/0092-8674(90)90512-D Breban, 1993, Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment, J. Exp. Med., 178, 1607, 10.1084/jem.178.5.1607 Taurog, 1994, The germ-free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats, J. Exp. Med., 80, 2359, 10.1084/jem.180.6.2359 Tran, 2006, Additional human beta-2m curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male B27 transgenic rats, Arthritis Rheum., 54, 1317, 10.1002/art.21740 Khare, 1995, Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2 microglobulin: a model of human spondylarthropathies, J. Exp. Med., 182, 1153, 10.1084/jem.182.4.1153 Sieper, 1998, Triggering mechanisms and T cell responses in the spondylarthropathies Hermann, 1993, HLA-B27 restricted CD8T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis, Lancet, 342, 646, 10.1016/0140-6736(93)91760-J Boyle, 2001, The recognition of HLA-B27 by human CD4+ T lymphocytes, J. Immunol., 67, 2619, 10.4049/jimmunol.167.5.2619 Sieper, 1993, T cells are responsible for the enhanced synovial cellular immune response to triggering antigen in reactive arthritis, Clin. Exp. Immunol., 91, 96, 10.1111/j.1365-2249.1993.tb03361.x Jardetsky, 1991, Identification of self peptides bound to purified HLA-B27, Nature, 353, 326, 10.1038/353326a0 Madden, 1991, The structure of HLA B27 reveals nonamer self peptides bound in an extended conformation, Nature, 353, 321, 10.1038/353321a0 Urban, 1994, A subset of HLA-B27 molecules contains peptides much longer than nonamers, Proc. Natl. Acad. Sci. USA, 91, 1534, 10.1073/pnas.91.4.1534 Atagunduz, 2005, HLA-B27 restricted CD8+ T cell response to cartilage derived self peptides in ankylosing spondylitis, Arthritis Rheum., 52, 892, 10.1002/art.20948 Fiorillo, 2000, CD8+ T cell autoreactivity to an HLA B27 restricted self epitope correlates with ankylosing spondylitis, J. Clin. Invest., 106, 47, 10.1172/JCI9295 Fiorillo, 2005, Allele dependent similarity between viral and self peptide presentation by HLA-B27 subtypes, J. Biol. Chem., 280, 2962, 10.1074/jbc.M410807200 Ruckert, 2006, Conformational dimorphism of self peptides and molecular mimicry in a disease associated HLA B27 subtype, J. Biol. Chem., 281, 2306, 10.1074/jbc.M508528200 Lahesmaa, 1992, Molecular mimicry in the pathogenesis of spondylarthropathies. A critical appraisal of cross reactivity between microbial antigens and HLA-B27, Br. J. Rheumatol., 31, 221, 10.1093/rheumatology/31.4.221 Schwimmbeck, 1987, Autoantibodies to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter syndrome. Molecular mimicry with Klebsellia pneumoniae as potential mechanism of autoimmune disease, J. Exp. Med., 166, 161, 10.1084/jem.166.1.173 Kapasi, 1992, HLA-B27 expression modulates Gram negative bacterial invasion into transfected L cells, J. Immunol., 148, 3554, 10.4049/jimmunol.148.11.3554 Virtala, 1997, HLA-B27 modulates intracellular survival of Salmonella enteriditis in human monocytic cells, Eur. J. Immunol., 27, 1331, 10.1002/eji.1830270606 Mear, 1999, Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondylarthropathies, J. Immunol., 163, 6665, 10.4049/jimmunol.163.12.6665 Dangoria, 2002, HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum, J. Biol. Chem., 277, 23459, 10.1074/jbc.M110336200 Colbert, 2010, From HLA-B27 to spondyloarthritis: a journey through the ER, Immunol. Rev., 233, 181, 10.1111/j.0105-2896.2009.00865.x Turner, 2005, HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response, J. Immunol., 175, 2438, 10.4049/jimmunol.175.4.2438 Toussirot, 2006, Decreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondylarthropathies, Ann. Rheum. Dis., 65, 279, 10.1136/ard.2005.037986 Allen, 2004, Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors, Curr. Mol. Med., 4, 59, 10.2174/1566524043479329 DeLay, 2009, HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with TH17 activation in transgenic rats, Arthritis Rheum., 60, 2633, 10.1002/art.24763 Turner, 2007, HLA-B27 up regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: implications for the pathogenesis of spondylarthritis-like disease, Arthritis Rheum., 56, 215, 10.1002/art.22295 Bowness, 2011, Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis, J. Immunol., 186, 2672, 10.4049/jimmunol.1002653 Pachebo-Tena, 2002, Innate immunity in host-microbial interactions: beyond B27 in the spondylarthropathies, Curr. Opin. Rheumatol., 14, 373, 10.1097/00002281-200207000-00007 Cedoz, 1995, The B7 cross reactive group and spondylarthropathies. An epidemiological approach, J. Rheumatol., 22, 1884 Monowarul Islam, 1995, HLA-DR8 and acute anterior uveitis in ankylosing spondylitis, Arthritis Rheum., 38, 547, 10.1002/art.1780380414 Rahman P, Elder JT. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005;64(suppl2):ii37–iii9. Callis Duffin, 2008, Genetics of psoriatic arthritis: update and future direction (GRAPPA 2007), J. Rheumatol., 35, 1449 Gudjonsson, 2006, Distinct clinical differences between HLA-Cw*602 positive and negative psoriasis patients: an analysis of 1019 HLA-C and HLA-B typed patients, J. Invest. Dermatol., 126, 740, 10.1038/sj.jid.5700118 Russell, 1972, HLA antigens associated with psoriasis, N. Engl. J. Med., 287, 738, 10.1056/NEJM197210122871503 Ikaheimo, 1996, HLA risk haplotype Cw6DR7DQA1*20201 and HLA-Cw6 with reference to the clinical picture of psoriasis vulgaris, Arch. Dermatol. Res., 288, 363, 10.1007/BF02507104 Nair, 2006, Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene, Am. J. Hum. Genet., 78, 827, 10.1086/503821 Gladman, 1999, HLA locus alleles in psoriatic arthritis, Hum. Immunol., 60, 259, 10.1016/S0198-8859(98)00123-2 Castelino, 2010, Genetic susceptibility factors for psoriatic arthritis, Curr. Opin. Rheumatol., 22, 152, 10.1097/BOR.0b013e32833669d2 Fournié, 1999, Proposition de critères de classification du rhumatisme psoriasique. Étude préliminaire de 260 patients, Rev. Rhum., 66, 513 Mendes, 2009, Behcet's disease. A contemporary review, J. Autoimmun., 32, 178, 10.1016/j.jaut.2009.02.011 Ono, 1973, HL-A5 and Behcet's disease, Lancet, 2, 1383, 10.1016/S0140-6736(73)93343-6 Ohno, 1982, Close association of HLA-Bw51 with Behcet's disease, Arch. Opthalmol., 100, 1455, 10.1001/archopht.1982.01030040433013 Ohno, 1978, HLA-Bw51 and Behcet's disease, JAMA, 240, 529, 10.1001/jama.1978.03290060031006 Azizleri, 1994, The association of HLA-B5 antigen with specific manifestations of Behcet's disease, Dermatology, 188, 293, 10.1159/000247169 de Menthon, 2009, HLA-B51/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies, Arthritis Rheum., 61, 1287, 10.1002/art.24642 Falk, 1995, Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behcet's disease. Int. Immunol., 7, 223 Schwartz, 1980, A public antigenic determinant in the HLA-B5 cross-reacting group-a basis for cross-reactivity and a possible link with Behcet's disease, Hum. Immunol., 1, 37, 10.1016/0198-8859(80)90008-7 International study group for Behcet's disease Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078–80. Imboden, 2009, The immunopathogenesis of rheumatoid arthritis, Annu. Rev. Pathol. Mech. Dis., 4, 417, 10.1146/annurev.pathol.4.110807.092254 Lee, 2008, Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus, Mol. Med., 14, 293, 10.2119/2007-00123.Lee Stastny, 1978, Association of the B cell alloantigen DRw4 with rheumatoid arthritis, N. Engl. J. Med., 298, 869, 10.1056/NEJM197804202981602 Holoshitz, 2010, The rheumatoid arthritis HLA-DRB1 shared epitope, Curr. Opin. Rheumatol., 22, 293, 10.1097/BOR.0b013e328336ba63 Gregersen, 1987, The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis Rheum., 30, 1205, 10.1002/art.1780301102 Wordsworth, 1992, HLA heterozygosity contributes to susceptibility to rheumatoid arthritis, Am. J. Hum. Genet., 51, 585 Weyand, 1992, Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis, J. Clin. Invest., 89, 2033, 10.1172/JCI115814 Mattey, 2001, HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against the development of rheumatoid arthritis, J. Rheumatol., 28, 232 Reviron, 2001, Influence of shared epitope negative HLA-DR alleles on genetic susceptibility to rheumatoid arthritis, Arthritis Rheum., 44, 535, 10.1002/1529-0131(200103)44:3<535::AID-ANR101>3.0.CO;2-Z de Vries, 2002, Reshaping the shared epitope hypothesis. HLA associated risk for rheumatoid arthritis is encoded by amino acid substitution at position 67-74 of the HLA-DRB1 molecule, Arthritis Rheum., 46, 921, 10.1002/art.10210 Tezenas du Montcel, 2005, New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility, Arthritis Rheum., 52, 1063, 10.1002/art.20989 Roudier, 1989, Susceptibility to rheumatoid arthritis maps to a T cell epitope shared by the HLA-Dw4 DRB1 chain and the Epstein Barr virus glycoprotein gp110, Proc. Natl. Acad. Sci. USA, 86, 5104, 10.1073/pnas.86.13.5104 Roudier, 1996, Molecular mimicry reflected through database screening: serendipity or survival strategy?, Immunol. Today, 17, 357, 10.1016/0167-5699(96)30021-2 Auger, 1996, HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70kD heat shock proteins, Nat. Med., 2, 306, 10.1038/nm0396-306 Auger, 1997, Afunction for the QKRAA amino acid motif: mediating binding of DNAJ to DNA k. Implications for the association of rheumatoid arthritis with HLA-DR4, J. Clin. Invest., 99, 1818, 10.1172/JCI119348 Huizinga, 2005, Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins, Arthritis Rheum., 52, 3433, 10.1002/art.21385 Cui, 2009, Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis, Mol. Med., 15, 136, 10.2119/molmed.2009.00008 Montes, 2011, Particular association of clinical and genetic features with auto-immunity to citrullinated alpha enolase in rheumatoid arthritis, Arthritis Rheum., 63, 654, 10.1002/art.30186 de Vries, 2011, Genetics of ACPA-positive rheumatoid arthritis: the beginning of the end?, Ann. Rheum. Dis., 70, i51, 10.1136/ard.2010.138040 Klareskog, 2006, A new model for the etiology of rheumatoid arthritis. Smoking may trigger HLA-DR shared epitope restricted immune reactions to autoantigens modified by citrullination, Arthritis Rheum., 54, 38, 10.1002/art.21575 Hill, 2003, The conversion of arginine to citrulline allows for high affinity peptide interaction with the rheumatoid arthritis associated HLA-DRB1*0401 MHC class II molecule, J. Immunol., 171, 538, 10.4049/jimmunol.171.2.538 Auger, 2005, Influence of HLA-DR genes on the production of rheumatoid arthritis specific autoantibodies to citrullinated fibrinogen, Arthritis Rheum., 52, 3424, 10.1002/art.21391 Morgan, 2009, Reevaluation of the interaction between HLA-DRB1 shared epitope alleles PTPN22 and smoking in determining susceptibility to autoantibody positive and autoantibody negative rheumatoid arthritis in a large UK caucasian population, Arthritis Rheum., 60, 2565, 10.1002/art.24752 Vignal, 2009, Genetic association of the major histocompatibility complex with rheumatoid arthritis implicates two non-DRB1 loci, Arthritis Rheum., 60, 53, 10.1002/art.24138 Price, 1999, The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases, Immunol. Rev., 167, 257, 10.1111/j.1600-065X.1999.tb01398.x Criswell, 2008, The genetic contribution to systemic lupus erythematosus, Bull. N. Y. Hosp. Jt. Dis., 66, 176 Candore, 2003, Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influence immunological parameters of healthy carriers of the haplotype, Biomed. Pharmacother., 57, 274, 10.1016/S0753-3322(03)00079-9 Lio, 2001, A genetically determined High setting of TNFa influences immunologic parameters of HLA-B8, DR3 positive subjects: Implications for autoimmunity, Hum. Immunol., 62, 705, 10.1016/S0198-8859(01)00264-6 Schork, 2009, Common vs Rare allele hypotheses for complex diseases, Curr. Opin. Genet. Dev., 19, 212, 10.1016/j.gde.2009.04.010